Epigenetic Status
Epigenetic status refers to the dynamic modifications to DNA and its associated proteins that influence gene activity without altering the underlying genetic code. Unlike the fixed DNA sequence, epigenetic marks can change in response to environmental factors, lifestyle, and aging, acting as a crucial interface between an individual's genes and their environment. These modifications dictate how and when genes are expressed, playing a fundamental role in cellular identity, development, and overall biological function.
The primary mechanisms contributing to epigenetic status include DNA methylation, histone modifications, and chromatin remodeling. DNA methylation typically involves the addition of a methyl group to a cytosine base, often within CpG dinucleotides, which can silence gene expression. Histone modifications, such as acetylation or methylation of histone proteins, alter the compaction of chromatin, thereby affecting the accessibility of DNA to transcriptional machinery. These modifications collectively establish distinct "chromatin states" that regulate gene expression programs across different cell types and developmental stages. [1]
The assessment of epigenetic status, particularly through "epigenetic clocks" based on DNA methylation patterns, has emerged as a significant indicator of biological age and health. These clocks can estimate an individual's biological age, which may differ from their chronological age, and have been associated with various health outcomes. Accelerated epigenetic aging has been linked to increased risks of cancer, cardiovascular disease, and all-cause mortality . [2], [3], [4] Furthermore, epigenetic status is implicated in the progression of age-related cognitive decline, including Alzheimer's disease [5] and other complex traits such as type 2 diabetes, inflammatory bowel disease, and obesity-related measures like waist circumference and waist-to-hip ratio. [6] Genetic variants can also influence epigenetic aging rates, with studies identifying associations between specific genetic loci and measures of epigenetic age acceleration. [6]
Understanding epigenetic status offers profound implications for public health and personalized medicine. By revealing how environmental factors such as diet, exercise, and education can modulate gene expression through epigenetic changes, it provides insights into disease prevention and intervention strategies. [7] The ability to measure and potentially modify epigenetic marks opens avenues for developing new diagnostics and therapies for age-related diseases, chronic conditions, and even for understanding the intergenerational transmission of environmental impacts on health.
Methodological and Statistical Constraints
Research into epigenetic status often faces significant methodological and statistical challenges that can influence the interpretation of findings. Studies must carefully manage quality control, including genotyping call rates, Hardy-Weinberg Equilibrium, and minor allele frequency filters, to ensure reliable variant inclusion. [8] Issues such as low minor allele counts or poor imputation quality in specific cohorts can lead to unstable results, necessitating stringent exclusion criteria to maintain data integrity. [9] Furthermore, the potential for effect-size inflation, sometimes referred to as "winner's curse," must be considered and addressed through appropriate statistical corrections. [10]
Another critical limitation arises from study design and statistical power. While meta-analyses combine data from multiple cohorts to increase sample size, potential overlap among participating cohorts needs careful management to avoid biased estimates. [9] The heterogeneity of effect sizes between different cohorts or even between sexes is a common concern that requires assessment using statistical methods like Cochran's Q statistic. [8] Replication of findings in independent samples is essential to validate initial discoveries, as some variants may not generalize, highlighting the need for robust follow-up studies. [11]
Generalizability and Ancestry-Specific Effects
The generalizability of findings concerning epigenetic status is often limited by the ancestral composition of study populations. Many large-scale genomic studies, including those on epigenetic aging rates, have primarily focused on individuals of European ancestry. [12] While analyses are frequently performed within specific ancestry groups and utilize ancestry-specific reference panels for quality control and imputation [9] this approach can restrict the applicability of results to more diverse global populations. Differences in causal variants, haplotype structures, or allele frequencies across ancestries can lead to varying effect sizes or even a lack of generalization for certain variants when tested in different ethnic groups. [11]
Such population-specific genetic architectures mean that associations identified in one ancestry may not hold true or may have different magnitudes of effect in others. For instance, some variants might exhibit lower minor allele frequencies in non-European populations, consequently reducing statistical power to detect associations in those groups. [11] Additionally, the prevalence of certain genetic factors, such as those related to hereditary hemochromatosis, can vary significantly by ancestry, leading to observed differences in effect sizes for associated traits. [11] These factors underscore the importance of multi-ancestry studies to ensure that genetic insights into epigenetic status are broadly applicable and equitable.
Phenotypic Nuance and Environmental Confounding
The precise definition and measurement of "epigenetic status" present inherent limitations, as current assays often rely on indirect or proxy measures. For example, epigenetic aging rates are typically derived from DNA methylation levels in blood [6] which, while highly correlated with flow cytometric measures of cell counts [6] represent a snapshot of a specific tissue and may not fully reflect the epigenetic landscape or aging processes across all tissues or the entire organism. The use of estimated blood cell counts based on DNA methylation levels, though validated, is still a surrogate measure.
Furthermore, environmental factors and gene-environment interactions introduce significant confounding challenges that can obscure direct genetic effects on epigenetic status. [12] Variables such as "smoking behavior" [9] dietary components like "iron in the diet" [11] and even physiological rhythms or states like the "time of the day when the blood was collected" or "menopausal status" [8] are known to influence epigenetic marks and related phenotypes. Disentangling the specific contributions of genetic variants from these pervasive environmental and lifestyle factors remains complex, contributing to remaining knowledge gaps and potentially "missing heritability" not yet explained by identified genetic variants.
Variants
Genetic variations play a crucial role in shaping an individual's biology, influencing gene activity, cellular pathways, and epigenetic status, which in turn can impact health and aging. Several variants across the genome have been identified for their associations with various traits, including epigenetic age acceleration, drug metabolism, and immune responses. These single nucleotide polymorphisms (SNPs) can reside within genes, in their regulatory regions, or in intergenic spaces, each potentially altering gene expression or protein function through diverse mechanisms.
A significant set of variants is associated with the intricate processes of aging and telomere maintenance. The _TERT_ gene, encoding the telomerase reverse transcriptase, is fundamental for maintaining telomere length, and variants such as *rs2736099* and *rs2736100* can influence its activity. Interestingly, alleles linked to longer leukocyte telomere length within the _TERT_ gene paradoxically correlate with higher intrinsic epigenetic age acceleration (IEAA), suggesting a complex interplay where _TERT_ has independent effects on telomere length and the epigenetic clock. [6] Experimental evidence has shown that _hTERT_ expression in human fibroblasts leads to a linear increase in DNA methylation age with cell population doubling, underscoring _TERT_'s critical role in regulating the epigenetic clock. [6] In the _KIF13A-NHLRC1_ locus, variants like *rs143093668*, *rs7744541*, and *rs6915893* are associated with epigenetic age acceleration, with *rs143093668* being near a CpG predictor for the epigenetic clock, implying its role in influencing DNA methylation patterns. [6] Similarly, *rs10937913* in _TNIP2_ is recognized as a leading marker for intrinsic epigenetic age acceleration (IEAA) and is linked to significant cis-eQTL (expression quantitative trait loci) effects, suggesting it influences the expression of nearby genes. [6] Another variant, *rs71007656*, located near _MTND1P18 - ZNF248_, also shows a positive association with intrinsic epigenetic age acceleration and significant cis-eQTL activity, indicating its impact on gene expression and, consequently, epigenetic regulation. [6] The _ZNF33CP - ZNF25_ locus, with variant *rs1005277*, is broadly associated with both intrinsic and extrinsic epigenetic age acceleration, highlighting the role of zinc finger proteins in regulating gene expression and chromatin structure, which are central to epigenetic control. [6]
Beyond aging, other variants influence a diverse range of cellular processes and epigenetic states. The _OXA1L-DT_ gene, associated with variant *rs182220862*, may function as a long non-coding RNA, influencing mitochondrial protein synthesis or assembly. Such non-coding RNAs can epigenetically regulate gene expression by modulating chromatin structure or transcription factor binding, thereby impacting cellular metabolism and potentially contributing to various complex traits. [6] The _RNU6-1018P - NEFHP2_ locus, featuring *rs189669793*, involves a small nuclear RNA (_RNU6-1018P_) crucial for RNA splicing and a pseudogene (_NEFHP2_). Variations in these regions can alter RNA processing efficiency or pseudogene-mediated gene regulation, both of which can lead to widespread changes in gene expression and the epigenetic landscape. [9] These alterations can affect how cells respond to environmental cues and maintain their identity, with broad implications for health.
Further variants influence critical aspects of drug metabolism and immune system function. The _TPMT_ gene, with variant *rs76244256*, encodes an enzyme responsible for metabolizing thiopurine drugs, which are used in treating certain cancers and autoimmune diseases. Variations in _TPMT_ can significantly alter enzyme activity, leading to individual differences in drug response, toxicity, and efficacy. Such metabolic variations can indirectly influence cellular stress pathways and subsequent epigenetic modifications, affecting disease progression or treatment outcomes. [9] The _MICA-AS1_ antisense RNA, associated with *rs28366133*, is involved in regulating the expression of the _MICA_ gene, which plays a key role in immune surveillance and inflammation. Changes caused by this variant could impact immune cell recognition and response, influencing the epigenetic regulation of immune pathways and contributing to susceptibility to various diseases. [6] Lastly, the _CARMIL1 - SCGN_ locus, including variant *rs73397619*, involves _CARMIL1_, a protein important for actin cytoskeleton dynamics, and _SCGN_, a calcium-binding protein found in neuroendocrine cells. Variations here can affect cellular architecture, signaling, and differentiation processes, which are tightly regulated by epigenetic mechanisms and can have widespread effects on tissue function and overall physiological balance. [9]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs76244256 | TPMT | epigenetic status |
| rs143093668 rs7744541 rs6915893 |
KIF13A - NHLRC1 | epigenetic status |
| rs182220862 | OXA1L-DT | epigenetic status |
| rs1005277 | ZNF33CP - ZNF25 | epigenetic status |
| rs2736099 rs2736100 |
TERT | epigenetic status eosinophil count basal cell carcinoma clonal hematopoiesis neutrophil count |
| rs10937913 | TNIP2 | epigenetic status |
| rs71007656 | MTND1P18 - ZNF248 | epigenetic status |
| rs189669793 | RNU6-1018P - NEFHP2 | epigenetic status |
| rs28366133 | MICA-AS1 | conotruncal heart malformations BMI-adjusted waist-hip ratio epigenetic status brain attribute BMI-adjusted waist circumference |
| rs73397619 | CARMIL1 - SCGN | epigenetic status |
Defining Epigenetic Status and its Measurement Approaches
Epigenetic status refers to the dynamic state of heritable modifications to DNA or its associated proteins that influence gene expression without altering the underlying DNA sequence. In research, this complex biological trait is often operationally defined and measured through quantifiable biomarkers, such as "epigenetic aging rates" and "epigenetic age acceleration". [6] These measures serve as indicators of an individual's biological age, which may diverge from their chronological age. The assessment of epigenetic status primarily involves profiling blood methylation data, which captures a specific subset of the epigenetic landscape, alongside analyses of histone modification marks that define chromatin states. [6]
Measurement approaches for epigenetic status involve detailed molecular analyses. For instance, "epigenetic age acceleration" is quantified using specific sets of CpGs, which are cytosine-guanine dinucleotides where methylation commonly occurs. [6] The comprehensive characterization of chromatin states relies on profiling five distinct histone modification marks, which are then integrated into sophisticated models to interpret their functional implications. [6] While blood methylation data offers valuable insights, studies acknowledge its limitations in fully capturing the dysfunction of other organ systems, indicating the tissue-specific nature of epigenetic regulation. [6]
Classification and Nomenclature of Epigenetic Markers
The terminology used to describe epigenetic status includes key concepts such as "epigenetic age acceleration," which is further delineated into intrinsic epigenetic age acceleration (IEAA) and extrinsic epigenetic age acceleration (EEAA). [6] These classifications represent distinct biological processes contributing to accelerated aging, allowing for a more nuanced understanding of the underlying epigenetic mechanisms. Beyond age-related metrics, the classification of "chromatin states" provides a systematic framework for categorizing genomic regions based on their epigenetic modifications.
A widely adopted classification system for chromatin involves a "15-state chromatin model," which is constructed from comprehensive profiling of specific histone modification marks across diverse cell and tissue lines. [6] This model enables researchers to assign functional annotations to genomic regions, such as active promoters, enhancers, or repressed regions, based on their unique epigenetic signatures. [6] This categorical approach to chromatin state annotations facilitates the interpretation of how epigenetic status contributes to gene regulation and cellular identity.
Clinical and Scientific Significance of Epigenetic Biomarkers
Epigenetic biomarkers, such as IEAA and EEAA, serve as crucial research criteria for investigating the genetic and environmental factors influencing biological aging and disease susceptibility. These biomarkers exhibit notable genetic correlations, suggesting a shared genetic architecture with other complex traits, and demonstrate modest phenotypic correlations, reinforcing their utility as measurable indicators. [6] The application of these markers extends to identifying potential causal relationships, with tentative evidence pointing to influences from blood lipid levels and educational attainment on epigenetic age acceleration. [6]
However, the interpretation of epigenetic status as a diagnostic or prognostic tool requires careful consideration of several factors. Studies indicate that epigenetic age acceleration can show relatively weak genetic correlations with many age-related traits, partly due to technical variation in measurement or the inherent tissue-specificity of epigenetic data. [6] For example, the impact of obesity on epigenetic age can vary significantly between different tissues, such as a strong effect observed in liver tissue versus a weak effect in blood tissue, underscoring the importance of tissue context in assessing epigenetic status. [6]
Biological Background of Epigenetic Status
Epigenetic status refers to the heritable changes in gene expression that occur without altering the underlying DNA sequence. These modifications play a crucial role in regulating cellular functions, development, and responses to environmental factors. The dynamic nature of the epigenome allows cells to adapt and maintain specific identities, influencing health and disease throughout an organism's lifespan.
Foundational Epigenetic Mechanisms
The epigenetic status of a cell is largely determined by a complex interplay of molecular modifications that regulate chromatin structure and gene accessibility. Key among these are DNA methylation, histone modifications, and the activity of non-coding RNAs such as microRNAs. DNA methylation typically involves the addition of a methyl group to cytosine bases, often leading to gene silencing when occurring in promoter regions, while histone modifications, such as acetylation of histone H3, can alter chromatin compaction, thereby influencing gene transcription. [13] These processes are facilitated by specific enzymes, including DNA 5-methylcytosine transferase I, which plays a role in stabilizing these marks. [14] Furthermore, microRNAs can regulate host inflammatory gene expression, demonstrating their critical role in modulating cellular responses to challenges like bacterial infections. [13]
These molecular mechanisms form intricate regulatory networks that dictate which genes are expressed and at what levels. For instance, in the context of Staphylococcus aureus infection, histone H3 acetylation and microRNAs are involved in regulating the host's inflammatory gene expression, highlighting their importance in cellular defense pathways. [13] The combined actions of these epigenetic marks contribute to the overall chromatin state, which can be annotated across various cell and tissue types, providing insights into the functional elements of the genome. [1]
Epigenetic Clocks and Cellular Aging
Epigenetic status is intimately linked to biological aging, with specific DNA methylation patterns serving as highly accurate "epigenetic clocks" to estimate an individual's biological age. These measures, often referred to as DNA methylation age (DNAm age) or epigenetic age acceleration (e.g., intrinsic and extrinsic epigenetic age acceleration, IEAA and EEAA), are derived from methylation levels at specific CpG sites across the genome. [6] While chronological age is a fixed measure, biological age as indicated by epigenetic clocks can vary, reflecting lifestyle, environmental exposures, and genetic predispositions. [15] These epigenetic clocks have been shown to correlate with physical and cognitive fitness, and even mortality, underscoring their relevance as biomarkers of overall health and longevity. [15]
The telomerase reverse transcriptase (TERT) gene plays a critical role in cellular aging and proliferation, and its expression significantly influences DNAm age. TERT is the catalytic subunit of telomerase, an enzyme that maintains telomere length, which is crucial for cellular replication capacity. [16] Studies indicate that TERT expression enables cells to record their proliferation history, with DNAm age tracking the cell division of stem and progenitor cells. [6] While critically short telomere length is known to trigger replicative senescence, epigenetic aging, particularly in TERT-expressing cells, appears to be distinct from this process, reflecting cumulative population doubling rather than a direct marker of senescence. [17]
Systemic Epigenetic Regulation and Disease
The epigenetic status exhibits tissue- and organ-specific variations, contributing to the diverse functions of different biological systems and their susceptibility to disease. For example, while obesity strongly affects the epigenetic age of liver tissue, its impact on blood tissue epigenetic age is comparatively weaker. [6] Epigenetic age acceleration in blood, however, has been linked to various complex traits and disease mechanisms, demonstrating its systemic consequences. These include metabolic disorders such as type 2 diabetes and gestational diabetes mellitus, where polymorphisms near genes like UBE2E2 are implicated. [18]
Furthermore, epigenetic alterations are associated with a range of pathophysiological processes, including inflammation, as seen in mastitis caused by Staphylococcus aureus infection. [13] Epigenetic age acceleration has also been correlated with an increased risk of age-related diseases like cancer, cardiovascular disease, and Alzheimer’s disease, as well as conditions such as Down syndrome. [3] The composition of blood cells, including T cells, B cells, and granulocytes, can also be estimated based on DNA methylation levels, highlighting the role of epigenetic status in immune system function and its potential implications for disease. [19]
Genetic Influences on Epigenetic Status
Genetic mechanisms play a significant role in shaping an individual's epigenetic landscape and their epigenetic aging rates. Studies have shown that both intrinsic and extrinsic epigenetic age acceleration are heritable traits, meaning a portion of their variation can be attributed to genetic factors. [6] Genome-wide association studies (GWAS) have identified specific genetic variants, or single nucleotide polymorphisms (SNPs), that are associated with epigenetic aging. For instance, the TERT locus is critically involved in influencing epigenetic aging rates, and variants near MLST8 and DHX57 have been found to affect the epigenetic age of the cerebellum. [6]
The interplay between genetic variants and epigenetic status can influence susceptibility to various complex traits. Genetic correlations indicate shared genetic influences between epigenetic age acceleration and certain age-related traits, although environmental factors often dwarf these shared genetic effects. [6] Mendelian randomization analyses provide tentative evidence for causal relationships, suggesting that factors like blood lipid levels and educational attainment might causally influence epigenetic age acceleration. [6] These findings underscore the intricate regulatory networks where genetic predispositions can modulate epigenetic modifications, thereby influencing disease risk and biological aging trajectories.
Epigenetic Signaling and Transcriptional Control
The epigenetic status of a cell is dynamically modulated by a complex interplay of extracellular signals and intracellular cascades that converge on transcriptional machinery. Signaling pathways, such as the Wnt-beta-catenin pathway, are crucial, with proteins like APC membrane recruitment 3 (APC_MR3) positively regulating its activity, thereby influencing cell proliferation and differentiation through downstream gene expression changes . This predictive capacity extends to lifespan, where epigenetic age acceleration has been shown to be a robust predictor. [6] Furthermore, the epigenetic age of specific tissues, such as the pre-frontal cortex, correlates with markers of neurodegeneration like neuritic plaques and amyloid load, and is linked to Alzheimer’s disease-related cognitive decline, suggesting its utility in assessing neurological health. [5]
Beyond general mortality and neurological conditions, epigenetic status provides insights into broader physiological function. The epigenetic clock, a measure derived from DNA methylation patterns, correlates with physical and cognitive fitness, offering a potential biomarker for overall aging and health span. [15] The ability to estimate blood cell counts using DNA methylation data, which highly correlates with flow cytometric measures, also presents a non-invasive monitoring strategy for immune cell composition, relevant in various clinical settings. [7] Such epigenetic biomarkers could serve as valuable tools for early detection and ongoing monitoring of age-related diseases and physiological changes.
Risk Stratification and Personalized Interventions
Epigenetic status offers a promising avenue for risk stratification, enabling the identification of individuals at higher risk for specific diseases and informing personalized medicine approaches. The observation that epigenetic age acceleration predicts serious health outcomes like cancer and cardiovascular disease allows for the stratification of patient populations based on their biological aging rate, rather than solely chronological age. [3] This stratification can guide targeted prevention strategies and earlier interventions for high-risk individuals. For instance, Mendelian randomization analyses have provided tentative evidence for causal influences of blood lipid levels on epigenetic age acceleration, suggesting that managing dyslipidemia could potentially impact epigenetic aging. [6]
Moreover, the interplay between genetics and epigenetics provides deeper insights for personalized medicine. Genetic variants near genes such as MLST8 and DHX57 have been shown to affect the epigenetic age of the cerebellum. [6] Similarly, variants at the TERT locus are associated with both telomere length and the risk of breast and ovarian cancer. [20] Understanding these genetic predispositions to altered epigenetic status can inform highly personalized prevention and treatment strategies, moving beyond a one-size-fits-all approach to patient care.
Associations with Systemic Health and Comorbidities
Epigenetic status is intricately linked to a spectrum of systemic health conditions and comorbidities, offering a broader understanding of disease pathogenesis. Significant genetic correlations have been observed between epigenetic aging rates and various complex traits, including waist circumference, waist-to-hip ratio, triglyceride levels, type 2 diabetes, Crohn’s disease, and age-related macular degeneration (AMD). [6] These associations highlight the pervasive influence of epigenetic regulation across multiple organ systems and disease pathways.
Furthermore, specific conditions are directly characterized by altered epigenetic profiles. Accelerated epigenetic aging is a recognized feature in syndromic presentations such as Down syndrome. [7] Lifestyle factors also play a role, with conditions like obesity demonstrating a strong effect on the epigenetic age of liver tissue, albeit a weaker effect on blood tissue. [6] Additionally, earlier onset of menarche and menopause has been causally associated with higher intrinsic epigenetic age acceleration. [6] These widespread associations underscore the potential of epigenetic status as an integrative biomarker reflecting overall physiological burden and contributing to the understanding of complex disease networks.
Frequently Asked Questions About Epigenetic Status
These questions address the most important and specific aspects of epigenetic status based on current genetic research.
1. Can my lifestyle choices truly slow down my 'biological' age?
Yes, absolutely. Your lifestyle, including diet, exercise, and even education, can significantly influence your epigenetic marks. These marks, unlike your fixed DNA, change dynamically and affect how your genes are expressed. By positively influencing these marks, you can potentially slow down your biological aging process, which is often measured by "epigenetic clocks."
2. If my family has a disease, can my habits really prevent it?
Yes, your habits can play a crucial role. While you might have a genetic predisposition, epigenetic changes, which are influenced by your environment and lifestyle, act as a key interface between your genes and health outcomes. By adopting healthy behaviors, you can modulate gene expression, potentially preventing or delaying the onset of conditions like heart disease or type 2 diabetes, even with a family history.
3. Could my grandparents' experiences affect my health today?
It's possible. Epigenetic research suggests the intergenerational transmission of environmental impacts on health. This means that significant environmental factors experienced by previous generations could leave epigenetic marks that influence gene expression in their descendants, potentially affecting your own health trajectory.
4. Does eating healthy actually change how my genes work?
Yes, in a way that matters for your health. Eating healthy doesn't change your fundamental DNA sequence, but it can profoundly alter how your genes are expressed. Diet is a powerful environmental factor that can modify epigenetic marks like DNA methylation and histone modifications, thereby influencing which genes are turned on or off and impacting your overall biological function.
5. Is there a test to find out my body's 'true' age?
Yes, there are now "epigenetic clocks" that can estimate your biological age. These tests typically analyze DNA methylation patterns, often from blood samples, to provide an age that might differ from your chronological age. This biological age has been linked to various health outcomes and risks for diseases.
6. Can everyday things I do affect my brain's aging?
Yes, they can. Your daily environment and lifestyle factors have a significant impact on your epigenetic status, which in turn influences gene expression in your brain. Accelerated epigenetic aging has been linked to age-related cognitive decline, including conditions like Alzheimer's disease, highlighting the connection between your habits and brain health.
7. Does my ancestry play a role in how fast I age?
Yes, it can. While epigenetic aging rates are influenced by many factors, studies on genetic variations that affect these rates have shown ancestry-specific differences. This means that genetic architectures and even the prevalence of certain genetic factors can vary across different ethnic groups, potentially influencing how fast your body ages biologically.
8. Why do I struggle with my waistline even when I try to eat well?
Your epigenetic status can influence how your body handles weight and fat distribution. Epigenetic marks, which are affected by lifestyle and environment, play a role in complex traits like obesity-related measures, including waist circumference. Even with good dietary efforts, individual epigenetic differences can contribute to varying outcomes.
9. Does chronic stress really make me age faster at a cellular level?
Yes, there's evidence for that. Stress is a significant environmental factor that can induce changes in your epigenetic marks. These modifications can impact gene expression, potentially accelerating your biological age, as measured by epigenetic clocks. This accelerated aging has been linked to increased risks for various health issues.
10. Why do some people stay healthier longer than others, despite similar habits?
Individual differences in epigenetic status and underlying genetic factors can contribute to varying health trajectories. Even with similar lifestyles, people can have different epigenetic marks that influence gene expression, affecting their susceptibility to age-related diseases and overall biological aging rates. These differences can explain why some individuals maintain better health for longer.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Roadmap Epigenomics Consortium et al. "Integrative analysis of 111 reference human epigenomes." Nature, vol. 518, no. 7539, 2015, pp. 317–330.
[2] Chen, B. H. et al. "DNA methylation-based measures of biological age: meta-analysis predicting time to death." Aging, vol. 8, no. 9, 2016, pp. 1844–1865.
[3] Perna, L. et al. "Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort." Clin. Epigenetics, vol. 8, no. 1, 2016, pp. 1–7.
[4] Christiansen, L. et al. "DNA methylation age is associated with mortality in a longitudinal Danish twin study." Aging Cell, vol. 15, no. 1, 2016, pp. 149–154.
[5] Levine, M. E. et al. "Epigenetic age of the prefrontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer’s disease related cognitive functioning." Aging, vol. 7, no. 11, 2015, pp. 1198–1211.
[6] Lu AT, et al. GWAS of epigenetic aging rates in blood reveals a critical role for TERT. Nat Commun. 2018;9:387.
[7] Horvath, S. et al. "Accelerated epigenetic aging in Down syndrome." Aging, vol. 7, no. 11, 2015, pp. 1159–1170.
[8] Benyamin, B., et al. "Common variants in TMPRSS6 are associated with iron status and erythrocyte volume." Nat Genet, 2009.
[9] Sung YJ, et al. A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure. Am J Hum Genet. 2018;102(3):375-400.
[10] Zhong, H., and Prentice, RL. "Correcting “winner’s curse” in odds ratios from genomewide association findings for major complex human diseases." Genet Epidemiol, 2010.
[11] Raffield, LM., et al. "Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation?" Hum Mol Genet, 2017.
[12] Dong, J., et al. "Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus." Clin Gastroenterol Hepatol, 2018.
[13] Modak, R. et al. "Epigenetic response in mice mastitis: Role of histone H3 acetylation and microRNA(s) in the regulation of host inflammatory gene expression during Staphylococcus aureus infection." Clinical epigenetics, vol. 6, 2014, p. 16.
[14] Young, J. I., et al. "Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I." J. Biol. Chem. 278 (2003): 19904–19908.
[15] Marioni, R. E. et al. "The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936." Int. J. Epidemiol., vol. 44, no. 4, 2015, pp. 1388–1396.
[16] Stampfer, M. R., et al. "Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor β growth inhibition in p16INK4A (−) human mammary epithelial cells." Proc. Natl Acad. Sci. USA 98 (2001): 4498–4503.
[17] Harley, C. B. "Telomere loss: mitotic clock or genetic time bomb?" Mutat. Res. 256 (1991): 271–282.
[18] Kim, H. G. et al. "WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome." Human molecular genetics, vol. 19, no. 19, 2010, pp. 3786–3795.
[19] Houseman, E., et al. "DNA methylation arrays as surrogate measures of cell mixture distribution." BMC Bioinform. 13 (2012): 86.
[20] Bojesen, S. E. et al. "Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer." Nat. Genet., vol. 45, 2013, pp. 371–384.